By | April 16, 2014

Louisiana Jury Orders Actos Manufacturer to Pay $9 Billion

Takeda Pharmaceutical Co. and Eli Lilly & Co. have been ordered to pay a total of $9 billion in punitive damages in connection to the diabetes drug Actos. A Louisiana jury found… Read More

By | March 31, 2014

Simmons Hanly Conroy Investigates Legal Rights of Car Owners Impacted by GM Recall

Illinois and Missouri residents who have owned or leased one of the vehicles related to the recall of General Motor cars with ignition problems may be able to hold the automaker accountable… Read More

By | March 31, 2014

Asbestos and Mesothelioma News Wrap Up: March 2014

At the Firm, our mesothelioma lawyers are committed to providing you with the latest asbestos and mesothelioma news to keep you up to date. Below is a short list of some of… Read More

By | March 20, 2014

New Video Sums Up Simmons Hanly Conroy Mission

Many people think asbestos has been banned in the United States. Sadly, it has not. Mesothelioma is still diagnosed in people across the country every year and helping these victims is one… Read More

By | March 14, 2014

Consolidation of Lipitor Lawsuits to Streamline Process

Currently 56 personal injury claims regarding Lipitor have been filed. More than 170 similar federal cases are pending in more than 40 districts before 100 different judges. As a result, the U.S.… Read More

By | March 13, 2014

National Environmental Group Files Suit Against Ameren

Sierra Club, a national environmental group, has sued the St. Louis-based utility company Ameren over “thousands of violations of federal clean air laws.” The group is asking the court to levy financial… Read More

By | March 11, 2014

Simmons Hanly Conroy Congratulates 2014 Asbestos Awareness Conference Award Winners

The 10th annual ADAO International Asbestos Awareness Conference is scheduled from April 4 to 6, 2014. The conference will feature more than 30 prominent experts and asbestos victims from around the world… Read More

By | March 7, 2014

FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs

More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More

By | March 3, 2014

Simmons Hanly Conroy Supports 2014 International Mesothelioma Symposium

The Firm is pleased to announce that it has renewed its support of the Mesothelioma Applied Research Foundation with a $25,000 donation to support the 2014 International Symposium on Malignant Mesothelioma. Over… Read More

By | February 28, 2014

Pharmaceutical News Wrap Up: February 2014

The pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls,… Read More

Topics

PAST ARTICLES